Prognostic Significance of Pre- and Posttreatment 18F-FDG PET/CT-Derived SUV-max in Esophageal Cancer: A South Asian Perspective

Sajida Qureshi; Waqas Ahmad Abbasi; Mehreen Ansari; Raheel Ahmed; Mubashir Iqbal; Hanieya Saiyed; Hira Abdul Jalil; Saba Mughal; Muhammad Saeed Quraishy; Sajida Qureshi; Waqas Ahmad Abbasi; Mehreen Ansari; Raheel Ahmed; Mubashir Iqbal; Hanieya Saiyed; Hira Abdul Jalil; Saba Mughal; Muhammad Saeed Quraishy

doi:10.1155/ecc/9653240

HTML

Rights and permissions

Copyright: © 2026 by the author(s). Exclusive Licensee Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.

About this article

Cite this article

Sajida Qureshi, Waqas Ahmad Abbasi, Mehreen Ansari, Raheel Ahmed, Mubashir Iqbal, Hanieya Saiyed, Hira Abdul Jalil, Saba Mughal, Muhammad Saeed Quraishy. 2026. Prognostic Significance of Pre- and Posttreatment 18F-FDG PET/CT-Derived SUV-max in Esophageal Cancer: A South Asian Perspective. European Journal of Cancer Care. 2026: doi: 10.1155/ecc/9653240

Sajida Qureshi, Waqas Ahmad Abbasi, Mehreen Ansari, Raheel Ahmed, Mubashir Iqbal, Hanieya Saiyed, Hira Abdul Jalil, Saba Mughal, Muhammad Saeed Quraishy. 2026. Prognostic Significance of Pre- and Posttreatment 18F-FDG PET/CT-Derived SUV-max in Esophageal Cancer: A South Asian Perspective. European Journal of Cancer Care. 2026: doi: 10.1155/ecc/9653240

{{lists.name}}

Prognostic Significance of Pre- and Posttreatment 18F-FDG PET/CT-Derived SUV-max in Esophageal Cancer: A South Asian Perspective

Rights and permissions

About this article

Cite this article

Article Metrics

Access History

Other Articles By Authors